The present invention relates to small molecule compounds and their use as agonists of farnesoid X receptor (FXR) and/or peroxisome proliferator activated receptor delta (PPARδ). The present invention also relates to the use of said compounds in the treatment of metabolic diseases and respective methods of treatment.
本发明涉及
小分子化合物及其作为法尼索类X受体(FXR)和/或
过氧化物酶体增生激活受体δ(
PPARδ)激动剂的用途。本发明还涉及所述化合物在治疗代谢性疾病中的应用以及相应的治疗方法。